CoreCap Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

CoreCap Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.7K	Hold	136	–	–	﹤0.01%	1591
2026 Q1	$27.3K	Hold	136	–	–	﹤0.01%	1548
2025 Q4	$28.1K	Sell	136 -55	-29%	-$11K	﹤0.01%	1551
2025 Q3	$34.2K	Sell	191 -37	-16%	-$6.3K	﹤0.01%	1465
2025 Q2	$36.8K	Hold	228	–	–	﹤0.01%	1369
2025 Q1	$38.8K	Sell	228 -101	-31%	-$17.5K	﹤0.01%	1275
2024 Q4	$54.6K	Sell	329 -25	-7%	-$4.27K	﹤0.01%	1150
2024 Q3	$60.9K	Buy	+354	New	+$58.6K	﹤0.01%	1114
2024 Q2	–	Sell	-489	Closed	-$75.2K	–	1905
2024 Q1	$75.2K	Buy	+489	New	+$74.6K	﹤0.01%	963
2022 Q4	$124K	Buy	+804	New	+$119K	0.01%	657
2022 Q3	–	Sell	-919	Closed	-$125K	–	1028
2022 Q2	$125K	Buy	+919	New	+$127K	0.01%	622
2022 Q1	–	Sell	-874	Closed	-$142K	–	1033
2021 Q4	$142K	Buy	+874	New	+$141K	0.01%	634

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

CoreCap Advisors's FBT Position: Q2 2026 in Review

CoreCap Advisors held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 136 shares worth $33.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1591.

CoreCap Advisors first reported a position in FBT in Q4 2021 and has held it in 12 quarters since. The position peaked at $142K in Q4 2021. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

CoreCap Advisors held 136 shares of First Trust NYSE Arca Biotechnology Index Fund worth $33.7K as of Q2 2026.
CoreCap Advisors left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1591 holding.
CoreCap Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and has held it in 12 quarters since.
CoreCap Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $142K in Q4 2021.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.